12:07 PM EST - Acasti Pharma Inc. : Announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office on its composition-of-matter patent application for “Concentrated Therapeutic Phospholipid Compositions.” The patent provides comprehensive coverage over a broad range of concentrated therapeutic phospholipid compositions. Acasti Pharma Inc.
shares V.ACST are trading unchanged at $0.71.
